Cited by

• Early evolution of the human immunodeficiency virus type 1 subtype C epidemic in rural Malawi.

  McCormack GP, Glynn JR, Crampin AC, Sibande F, Mulawa D, Bliss L, Broadbent P, Abarca K, Pönnighaus JM, Fine PE, Clewley JP. McCormack GP, et al. J Virol. 2002 Dec;76(24):12890-9. doi: 10.1128/jvi.76.24.12890-12899.2002. J Virol. 2002. PMID: 12438614 Free PMC article.
• Failure of Mycobacterium leprae soluble antigens to suppress delayed-type hypersensitivity reaction to tuberculin.

  Fine PE, Gruer PJ, Maine N, Ponnighaus JM, Rees RJ, Stanford JL. Fine PE, et al. Clin Exp Immunol. 1989 Aug;77(2):226-9. Clin Exp Immunol. 1989. PMID: 2673590 Free PMC article. Clinical Trial.
• Contribution of remote M.tuberculosis infection to tuberculosis disease: A 30-year population study.

  Glynn JR, Khan P, Mzembe T, Sichali L, Fine PEM, Crampin AC, Houben RMGJ. Glynn JR, et al. PLoS One. 2023 Jan 27;18(1):e0278136. doi: 10.1371/journal.pone.0278136. eCollection 2023. PLoS One. 2023. PMID: 36706117 Free PMC article.
• Monitoring the impact of decentralised chronic care services on patient travel time in rural Africa--methods and results in Northern Malawi.

  Houben RM, Van Boeckel TP, Mwinuka V, Mzumara P, Branson K, Linard C, Chimbwandira F, French N, Glynn JR, Crampin AC. Houben RM, et al. Int J Health Geogr. 2012 Nov 15;11:49. doi: 10.1186/1476-072X-11-49. Int J Health Geogr. 2012. PMID: 23153311 Free PMC article.
• BCG re-vaccination in Malawi: 30-year follow-up of a large, randomised, double-blind, placebo-controlled trial.

  Glynn JR, Fielding K, Mzembe T, Sichali L, Banda L, McLean E, Kanjala C, Crampin AC, Ponnighaus JM, Warndorff DK, Fine PEM; Karonga Prevention Trial Group. Glynn JR, et al. Lancet Glob Health. 2021 Oct;9(10):e1451-e1459. doi: 10.1016/S2214-109X(21)00309-0. Lancet Glob Health. 2021. PMID: 34534489 Free PMC article.